Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats

Endocrinology

Volumn 149, Issue 1, 2008, Pages 237-244

  Schwenke, Daryl O ^a,c   Tokudome, Takeshi ^a   Shirai, Mikiyasu ^b   Hosoda, Hiroshi ^a   Horio, Takeshi ^a   Kishimoto, Ichiro ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GHRELIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; CONSCIOUSNESS; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; GENE OVEREXPRESSION; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOLOGY; HYPOXIA; LUNG ALVEOLUS HYPOXIA; MALE; MORPHOMETRICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SPRAGUE DAWLEY RAT; TELEMETRY; TREATMENT OUTCOME;

ALGORITHMS; ANIMALS; ANOXIA; BLOOD GLUCOSE; BODY WEIGHT; CHRONIC DISEASE; CONSCIOUSNESS; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; ENDOTHELIN-1; FATTY ACIDS, NONESTERIFIED; GHRELIN; HEMODYNAMICS; HYPERTENSION, PULMONARY; MALE; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 37549060716     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0833     Document Type: Article

References (70)

1. Barbera JA, Peinado VI, Santos S 2000 Pulmonary hypertension in COPD: old and new concepts. Monaldi Arch Chest Dis 55:445-449
2. Voelkel NF, Tuder RM 2000 Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 106:733-738
3. Johnson W, Nohria A, Garrett L, Fang JC, Igo J, Katai M, Ganz P, Creager MA 2002 Contribution of endothelin to pulmonary vascular tone under normoxic and hypoxic conditions. Am J Physiol Heart Circ Physiol 283:H568-H575
4. Yuan JX, Rubin LJ 2005 Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. Circulation 111:534-538
5. Imamura M, Luo B, Limbird J, Vitello A, Oka M, Ivy DD, McMurtry IF, Garat CV, Fallon MB, Carter EP 2005 Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation. J Appl Physiol 98:739-747
6. Adnot S, Raffestin B, Eddahibi S, Braquet P, Chabrie PE 1991 Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest 87:155-162
7. Carville C, Raffestin B, Eddahibi S, Blouquit Y, Adnot S 1993 Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rats exposed to chronic hypoxia: effects of in vivo and in vitro supplementation with L-arginine. J Cardiovasc Pharmacol 22:889-896
8. Fike CD, Kaplowitz MR, Thomas CJ, Nelin LD 1998 Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lungs. Am J Physiol 274 (4 Pt 1):L517-L526
9. Le Cras TD, McMurtry IF 2001 Nitric oxide production in the hypoxic lung. Am J Physiol Lung Cell Mol Physiol 280:L575-L582
10. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660
11. Nagaya N, Uematsu M, Kojima M, Date Y, Nakazato M, Okumura H, Hosoda H, Shimizu W, Yamagishi M, Oya H, Koh H, Yutani C, Kangawa K 2001 Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 104:2034-2038
12. Nagaya N, Itoh T, Murakami S, Oya H, Uematsu M, Miyatake K, Kangawa K 2005 Treatment of cachexia with ghrelin in patients with COPD. Chest 128:1187-1193
13. Nagaya N, Kangawa K 2003 Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 3:146-151
14. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, Ueno K, Kitakaze M, Miyatake K, Kangawa K 2004 Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110:3674-3679
15. Okumura H, Nagaya N, Enomoto M, Nakagawa E, Oya H, Kangawa K 2002 Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol 39:779-783
16. Nagaya N, Uematsu M, Kojima M, Ikeda Y, Yoshihara F, Shimizu W, Hosoda H, Hirota Y, Ishida H, Mori H, Kangawa K 2001 Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104:1430-1435
17. Wiley KE, Davenport AP 2002 Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 136:1146-1152
18. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K 1993 Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73:887-897
19. Chen SJ, Chen YF, Meng QC, Durand J, Dicarlo VS, Oparil S 1995 Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J Appl Physiol 79:2122-2131
20. Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R, Jr., Baptista MJ, Lourenco AP, Oliveira SM, Brandao-Nogueira A, Teles A, Fortunato JM, Leite-Moreira AF 2004 Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 287:H2885-H2890
21. Henriques-Coelho T, Roncon-Albuquerque Junior R, Lourenco AP, Baptista MJ, Oliveira SM, Brandao-Nogueira A, Correia-Pinto J, Leite-Moreira AF 2006 Ghrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertension. Rev Port Cardiol 25:55-63
22. Soares JB, Rocha-Sousa A, Castro-Chaves P, Henriques-Coelho T, Leite-Moreira AF 2006 Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. Peptides 27:1616-1623
23. Soares JB, Rocha-Sousa A, Castro-Chaves P, Henriques-Coelho T, Lourenco AP, Roncon-Albuquerque Jr R, Leite-Moreira AF 2005 Contractile effects of Ghrelin and expression of its receptor GHS-R1a in normal and hypertrophic myocardium. Rev Port Cardiol 24:1235-1242
24. Rocha-Sousa A, Saraiva J, Henriques-Coelho T, Falcao-Reis F, Correia-Pinto J, Leite-Moreira AF 2006 Ghrelin as a novel locally produced relaxing peptide of the iris sphincter and dilator muscles. Exp Eye Res 83:1179-1187
25. Lourenco AP, Roncon-Albuquerque Jr R, Bras-Silva C, Faria B, Wieland J, Henriques-Coelho T, Correia-Pinto J, Leite-Moreira AF 2006 Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 291:H1587-H1594
26. Horstman DJ, Frank DU, Rich GF 1998 Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats. Anesth Analg 86:74-81
27. Raoul W, Wagner-Ballon O, Saber G, Hulin A, Marcos E, Giraudier S, Vainchenker W, Adnot S, Eddahibi S, Maitre B 2007 Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice. Respir Res 8:8
28. van Suylen RJ, Smits JF, Daemen MJ 1998 Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am J Resp Crit Care Med 157:1423-1428
29. Schwenke DO, Pearson JT, Mori H, Shirai M 2006 Does central nitric oxide elicit pulmonary hypertension in conscious rats? Respir Physiol Neurobiol 153:250-260
30. Bunag RD 1973 Validation in awake rats of a tail-cuff method for measuring systolic pressure. J Appl Physiol 34:279-282
31. Yu Y, Ohmori K, Chen Y, Sato C, Kiyomoto H, Shinomiya K, Takeuchi H, Mizushige K, Kohno M 2004 Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model. J Am Coll Cardiol 44:904-913
32. Tokudome T, Horio T, Kishimoto I, Soeki T, Mori K, Kawano Y, Kohno M, Garbers DL, Nakao K, Kangawa K 2005 Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. Circulation 111:3095-3104
33. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K 2000 Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35:19-24
34. Nagaya N, Kojima M, Kangawa K 2006 Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern Med 45:127-134
35. Katugampola SD, Pallikaros Z, Davenport AP 2001 [125I-His9]-Ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue; up-regulation of receptors with atherosclerosis. Br J Pharmacol 134:143-149
36. Yang X, Chen W, Li F 2000 [The change and distribution of endothelin-1 in lung of hypoxic pulmonary hypertension rat]. Hua Xi Yi Ke Da Xue Xue Bao 31:30-33 (Chinese)
37. Blumberg FC, Lorenz C, Wolf K, Sandner P, Riegger GA, Pfeifer M 2002 Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertension. Cardiovasc Res 55:171-177
38. Giaid A 1998 Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 114(3 Suppl):208S-212S
39. Shimoda LA, Sham JS, Sylvester JT 2000 Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol Res 49:549-560
40. Wu R, Dong W, Zhou M, Cui X, Hank Simms H, Wang P 2005 Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc Res 68:318-326
41. Jernigan NL, Walker BR, Resta TC 2004 Endothelium-derived reactive oxygen species and endothelin-1 attenuate NO-dependent pulmonary vasodilation following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 287:L801-L-808
42. Maruyama J, Maruyama K 1994 Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats. Am J Physiol 266(6 Pt 2):H2476-H2488
43. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM 1994 Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol 267(5 Pt 1):C1405-C1413
44. Sato J, Nair K, Hiddinga J, Eberhardt NL, Fitzpatrick LA, Katusic ZS, O'Brien T 2000 eNOS gene transfer to vascular smooth muscle cells inhibits cell proliferation via upregulation of p27 and p21 and not apoptosis. Cardiovasc Res 47:697-706
45. Xue C, Rengasamy A, Le Cras TD, Koberna PA, Dailey GC, Johns RA 1994 Distribution of NOS in normoxic vs. hypoxic rat lung: upregulation of NOS by chronic hypoxia. Am J Physiol 267(6 Pt 1):L667-L678
46. Shirai M, Pearson JT, Shimouchi A, Nagaya N, Tsuchimochi H, Ninomiya I, Mori H 2003 Changes in functional and histological distributions of nitric oxide synthase caused by chronic hypoxia in rat small pulmonary arteries. Br J Pharmacol 139:899-910
47. Le Cras TD, Xue C, Rengasamy A, Johns RA 1996 Chronic hypoxia upregulates endothelial and inducible NO synthase gene and protein expression in rat lung. Am J Physiol 270(1 Pt 1):L164-L170
48. Sato K, Rodman DM, McMurtry IF 1999 Hypoxia inhibits increased ETB receptor-mediated NO synthesis in hypertensive rat lungs. Am J Physiol 276(4 Pt 1):L571-L581
49. Crawley DE, Zhao L, Giembycz MA, Liu S, Barnes PJ, Winter RJ, Evans TW 1992 Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am J Physiol 263(3 Pt 1):L325-L332
50. Murata T, Yamawaki H, Hori M, Sato K, Ozaki H, Karaki H 2001 Hypoxia impairs endothelium-dependent relaxation in organ cultured pulmonary artery. Eur J Pharmacol 421:45-53
51. Bakker EN, van der Linden PJ, Sipkema P 1997 Endothelin-1-induced constriction inhibits nitric-oxide-mediated dilation in isolated rat resistance arteries. J Vasc Res 34:418-424
52. Rossi GP, Seccia TM, Nussdorfer GG 2001 Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int Rev Cytol 209:241-272
53. Fresquet F, Pourageaud F, Leblais V, Brandes RP, Savineau JP, Marthan R, Muller B 2006 Role of reactive oxygen species and gp91phox in endothelial dysfunction of pulmonary arteries induced by chronic hypoxia. Br J Pharmacol 148:714-723
54. Rubanyi GM, Vanhoutte PM 1986 Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250(5 Pt 2):H822-H827
55. Everett AD, Le Cras TD, Xue C, Johns RA 1998 eNOS expression is not altered in pulmonary vascular remodeling due to increased pulmonary blood flow. Am J Physiol 274(6 Pt 1):L1058-L1065
56. Le Cras TD, Tyler RC, Horan MP, Morris KG, McMurty IF, Johns RA, Abman SH 1998 Effects of chronic hypoxia and altered hemodynamics on endothelial nitric oxide synthase and preproendothelin-1 expression in the adult rat lung. Chest 114(1 Suppl):35S-36S
57. Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T, Kangawa K, Kohno N, Yoshizumi M 2003 Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 310:830-835
58. Iantorno M, Chen H, Kim JA, Tesauro M, Lauro D, Cardillo C, Quon MJ 2007 Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells. Am J Physiol Endocrinol Metab 292:E756-E764
59. Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D, Cardillo C 2005 Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 112:2986-2992
60. Reeve HL, Michelakis E, Nelson DP, Weir EK, Archer SL 2001 Alterations in a redox oxygen sensing mechanism in chronic hypoxia. J Appl Physiol 90:2249-2256
61. Bunag RD 1983 Facts and fallacies about measuring blood pressure in rats. Clin Exp Hypertens 5:1659-1681
62. McMurtry IF, Petrun MD, Reeves JT 1978 Lungs from chronically hypoxic rats have decreased pressor response to acute hypoxia. Am J Physiol 235:H104-H109
63. Huang KL, Wu CP, Kang BH, Lin YC 2002 Chronic hypoxia attenuates nitric oxide-dependent hemodynamic responses to acute hypoxia. J Biomed Sci 9:206-212
64. Weissmann N, Nollen M, Gerigk B, Ardeschir Ghofrani H, Schermuly RT, Gunther A, Quanz K, Fink L, Hanze J, Rose F, Seeger W, Grimminger F 2003 Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide. Am J Physiol Heart Circ Physiol 284:H931-H938
65. Zhao L, Crawley DE, Hughes JM, Evans TW, Winter RJ 1993 Endothelium-derived relaxing factor activity in rat lung during hypoxic pulmonary vascular remodeling. J Appl Physiol 74:1061-1065
66. Hampl V, Archer SL, Nelson DP, Weir EK 1993 Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. J Appl Physiol 75:1748-1757
67. Emery CJ, Bee D, Barer GR 1981 Mechanical properties and reactivity of vessels in isolated perfused lungs of chronically hypoxic rats. Clin Sci (Lond) 61:569-580
68. Clini E, Cremona G, Campana M, Scotti C, Pagani M, Bianchi L, Giordano A, Ambrosino N 2000 Production of endogenous nitric oxide in chronic obstructive pulmonary disease and patients with cor pulmonale. Correlates with echo-Doppler assessment. Am J Resp Crit Care Med 162:446-450
69. Karamsetty VS, MacLean MR, McCulloch KM, Kane KA, Wadsworth RM 1996 Hypoxic constrictor response in the isolated pulmonary artery from chronically hypoxic rats. Respir Physiol 105:85-93
70. Moudgil R, Michelakis ED, Archer SL 2005 Hypoxic pulmonary vasoconstriction. J Appl Physiol 98:390-403